by James Radke, PhD | Aug 3, 2022
Annette von Drygalski, MD, PharmD, Associate Clinical Professor of Medicine in the Division of Hematology/Oncology, and Director of the Hemophilia and Thrombosis Treatment Center, Department of Medicine, at the University of California, San Diego, discusses...
by James Radke, PhD | Jul 29, 2022
Paula Busse, MD, Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai, provides a summary of the latest information about hereditary angioedema (HAE) that was presented at the American Academy of Allergy, Asthma, & immunology 2022...
by James Radke, PhD | Jul 15, 2022
Evan S. Dellon, MD, MPH, Gastroenterologist, and Professor of Medicine and Adjunct Professor of Epidemiology at the University of North Carolina Chapel Hill, explains two things that physicians should know about eosinophilic esophagitis (EoE). EoE is a chronic,...
by James Radke, PhD | Jun 24, 2022
P.J. Brooks, PhD, Acting Director of the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences (NCATS), describes NCATS’ push to increase efficiency and decrease costs in the development of rare disease treatments. As Dr....
by James Radke, PhD | Jun 17, 2022
The U.S. Food and Drug Administration has approved a supplemental indication for setmelanotide (Imcivree) for chronic weight management in patients ≥6 years of age with obesity due to Bardet-Biedl Syndrome (BBS). BBS is a rare genetic disease that impairs the hunger...
